Azelaic Acid (Compound)

Synonyms:azelaic acid, NONANEDIOIC ACID, 123-99-9, Finacea, Anchoic acid, Azelex, Lepargylic acid, 1,7-Heptanedicarboxylic acid, Skinoren, 1,9-Nonanedioic acid, Heptanedicarboxylic acid, n-Nonanedioic acid, Emerox 1110, Emerox 1144, azelate, acide azelaique, Finevin, Azelainic acid, acidum azelaicum, Skinorem, 1,7-Dicarboxyheptane, Azelaic acid, technical grade, Emery's L-110, ZK 62498, ZK-62498, 26776-28-3, NSC 19493, CHEBI:48131, NSC-19493, Water-soluble azelaic acid, F2VW3D43YT, MLS000069659, DTXSID8021640, NSC19493, MFCD00004432, NCGC00014993-07, SMR000059164, Acido azelaico, Azalaic Acid, Acide azelaique [French], Acido azelaico [Spanish], Acidum azelaicum [Latin], heptane-1,7-dicarboxylic acid, Azelaic acid [USAN:INN], DTXCID501640, Azelaic, CAS-123-99-9, Finacea (TN), Azelex (TN), SR-01000075671, EINECS 204-669-1, UNII-F2VW3D43YT, Azelaic acid (USAN/INN), BRN 1101094, Azelaicacidtech, Azelainsaeure, Lepargylate, Nonandisaeure, Anchoate, azelaic-acid, n-Nonanedioate, AI3-06299, HSDB 7659, 1tuf, 1,9-Nonanedioate, SH-441, AGN-191861, Azelaic acid, 98%, Spectrum_000057, Water-solubleazelaicacid, Opera_ID_740, 1,7-Heptanedicarboxylate, Spectrum2_000995, Spectrum3_000278, Spectrum4_000401, Spectrum5_001304, AZELAIC ACID [MI], Epitope ID:187039, A-9800, EC 204-669-1, AZELAIC ACID [INN], Lopac-246379, SCHEMBL3887, AZELAIC ACID [HSDB], AZELAIC ACID [INCI], AZELAIC ACID [USAN], CHEMBL1238, Lopac0_000051, AZELAIC ACID [VANDF], BSPBio_001756, KBioGR_000662, KBioSS_000437, Nonanedioic acid Azelaic acid, 4-02-00-02055 (Beilstein Handbook Reference), MLS001148615, AZELAIC ACID [MART.], BIDD:GT0315, DivK1c_000532, SPECTRUM1500648, SPBio_001089, AZELAIC ACID [WHO-DD], GTPL7484, HMS501K14, KBio1_000532, KBio2_000437, KBio2_003005, KBio2_005573, KBio3_001256, Azelaic acid, analytical standard, NINDS_000532, HMS1921O11, HMS2092E22, HMS2234D10, HMS3260K03, HMS3372J07, Pharmakon1600-01500648, AZELAIC ACID [ORANGE BOOK], BCP18690, HY-B0704, Tox21_110063, Tox21_201989, Tox21_303011, Tox21_500051, Azelaic acid, technical grade, 80%, CCG-40081, LMFA01170054, NSC757406, s4550, STL059432, AKOS000120052, Tox21_110063_1, Azelaic acid, technical, ~85% (GC), Azelaic acid, Vetec(TM) reagent grade, DB00548, KS-5293, LP00051, NSC-757406, SDCCGMLS-0066619.P001, SDCCGMLS-0066619.P033, SDCCGSBI-0050040.P004, IDI1_000532, MLS-0066619, NCGC00014993-01, NCGC00014993-02, NCGC00014993-03, NCGC00014993-04, NCGC00014993-05, NCGC00014993-06, NCGC00014993-08, NCGC00014993-09, NCGC00014993-10, NCGC00014993-12, NCGC00014993-15, NCGC00093565-01, NCGC00093565-02, NCGC00093565-03, NCGC00093565-04, NCGC00093565-05, NCGC00093565-06, NCGC00093565-07, NCGC00256508-01, NCGC00259538-01, NCGC00260736-01, BP-27863, MLS-0066619.P021, SBI-0050040.P003, A0561, Dicarboxylic acid C9; Nonanedioic acid; AZA, EU-0100051, FT-0626920, EN300-18040, C08261, D03034, D70171, AB00052140_12, Q413504, SR-01000075671-1, SR-01000075671-4, SR-01000075671-6, 0C50D8EC-0DB0-4F24-8EFC-2919E1F0D9BF, Z57127532, F8889-5093
Id:2266
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Azelaic Acid's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Azelaic Acid.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Azelaic Acid.

Results found

Linked to

 

Label

Description

 

Substance

A Substance

Collection

DrugPage Collection: (DrugCentralID:00270; PubChem_CID:2266, FILE=drugcentral_drug_00270.json)

Collection

Metadatata for azelaic acid


  • Collection

    DrugPage Collection: (DrugCentralID:00270; PubChem_CID:2266, FILE=drugcentral_drug_00270.json)


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.